AZ-LIMELIGHT-NETWORKS
8.9.2020 16:28:09 CEST | Business Wire | Press release
Limelight Networks, Inc. (Nasdaq: LLNW ), a leading provider of content delivery network (CDN) and edge cloud services, has expanded its edge capabilities by launching EdgeFunctions, a new serverless compute service which allows developers to tap into the power of the company’s global network and gives them the flexibility to deploy and run their own code.
EdgeFunctions provides a customizable environment at the network edge for streamlining content workflows, performing time-sensitive decisions, and customizing user experiences. Providing this environment at the network edge offers Limelight’s low latency, on-demand scalability and high-performance network to developers. EdgeFunctions is ideal for streaming video and content delivery use cases such as personalized streaming, content protection, dynamic ad insertion, A/B testing, and image manipulation. Functions are globally available in Limelight’s highly distributed network and run closest to where content requests are received, ensuring Limelight’s lowest possible latency for code execution and optimal user experiences.
“We are thrilled to partner with Limelight to integrate our NexGuard Streaming forensic watermarking technology with EdgeFunctions and safeguard a premium OTT provider’s content from leaks and piracy,” said Jean-Philippe Plantevin, VP Anti-Piracy at NAGRA, a leading provider of content protection and multiscreen TV solutions. “Using EdgeFunctions, we were able to quickly deploy our customized solution into Limelight’s network edge locations and run them on demand, at scale, for both VOD and live OTT watermarking workflows.”
EdgeFunctions leverages Limelight’s global network to put flexibility and power directly into the hands of developers with support for several programming languages including Node.js, Python and Go. Its APIs enable these developers to manage, deploy and run their functions at the network edge and take advantage of Limelight’s direct peering connections with more than 1,000 ISPs and leading public cloud providers.
“Edge technology and solutions are rapidly expanding to meet a diverse set of customer needs. Limelight has an extensive global network with edge locations across the globe,” said Dave McCarthy, Research Director, Edge Strategies at IDC. “Giving developers more dynamic control over content combined with Limelight’s extensive global network optimizes the delivery of video at the edge.”
EdgeFunctions is Limelight’s latest innovation in the company’s edge compute solutions. These edge compute solutions now include serverless, virtual machine and bare metal solutions, providing edge compute capabilities how and where customers need them. In 2018 Limelight launched its first Edge Compute offering that allowed customers to access a highly connected environment that delivers low latency by combining globally distributed compute power with Limelight's high-performance network.
“We’ve evolved beyond high performing online video delivery with new innovative solutions to enhance online experiences and provide real value to our customers in ways that only we can. Now developers have the power to create and run bandwidth-intensive, latency-sensitive applications throughout our network edge,” said Bob Lento, CEO at Limelight. “Our extensive Edge Compute offering coupled with EdgeFunctions provides one of the most comprehensive content delivery and edge tool sets available today, and we have a robust development pipeline with much more to come. I’m thrilled to provide these services to the world’s leading companies.”
About Limelight
Limelight Networks, Inc. (NASDAQ: LLNW) is a global leader in delivering the highest quality online video experiences and edge-enabled workflows. Limelight has successfully helped launch and grow the largest video properties in the world and is on the forefront of enabling a new generation of applications that will disrupt markets and change our world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005739/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press release
Special-Edition Korea-Made Skin Care Collection Launches In 40 Markets, Available While Supplies Last Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press release
Broadens GE HealthCare's footprint in the U.S. radiopharmaceutical industry, drives patient access to F18 labeled Positron Emission Tomography (PET) radiopharmaceuticals and enhances exposure to new high-growth areas Pharmaceutical Diagnostics (PDx) continues to partner with other established Contract Manufacturing Organizations (CMOs) to drive and expand patient access to its radiopharmaceutical portfolio, while SOFIE Biosciences continues to supply PET products from other leading radiopharmaceutical providers Provides U.S. rights to FAPI-74, a Phase III pipeline PET radiotracer with pan-cancer imaging potential, aiming to be among the first-to-launch in a large and fast-growing market1 GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subje
Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press release
The installation marks a significant step in the evolution of premium No/Low wines, where preserving aroma and sensory quality has become a defining industry priority. Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking exper
Croma-Pharma Expands Its Portfolio in Canada With saypha® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press release
Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia
Anaeco Secures Strategic Investment from Momentum Global Ventures to Accelerate Commercial Deployment5.10.2026 12:00:00 CEST | Press release
Investment supports commercialization across anesthetics, refrigerants, and semiconductor manufacturing Anaeco, Inc., a clean technology company developing systems to destroy harmful and difficult-to-abate gases, today announced a strategic investment from Momentum Global Ventures. The investment supports Anaeco as it moves from technology development and validation to commercial deployment across three initial markets: anesthetic gases, refrigerants, and semiconductor manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005546122/en/ Anaeco’s technology exploits atmospheric chemistry to destroy harmful, high-impact gases, including HFCs, PFAS, anesthetic gases, N2O, and other difficult-to-abate emissions at their source. By accelerating processes that naturally transform pollutants, its modular technology provides a practical, scalable approach to emissions that are difficult or costly to manage conventionally.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom